NivoIpiliReconstruct: Approximate survival data for Nivolumab plus Ipilimumab
In nchenderson/DelayedSurvFit: Constrained Survival Estimation with Delayed Treatment
NivoIpili R Documentation
Approximate survival data for Nivolumab plus Ipilimumab
Description
Reconstructed survival data from a study involving
the comparison of Nivolumab plus Ipilimumab vs. chemotherapy
in the treatment of patients having advanced non–small-cell lung cancer.
Usage
data("NivoIpili")
Format
A data frame with 1166 observations on the following 3 variables.
timesvector of follow-up times
evntvector of event indicators
trttreatment assignment indicators; 1 - Nivolumab + Ipili, 0 - chemotherapy
Details
Approximate survival data reconstructed from survival curves extracted
from Hellmann et al. (2019)
Source
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
References
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
Examples
data(NivoIpili)
head(NivoIpili)
nchenderson/DelayedSurvFit documentation built on Aug. 18, 2024, 11:49 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| NivoIpili | R Documentation |
Approximate survival data for Nivolumab plus Ipilimumab
Description
Reconstructed survival data from a study involving the comparison of Nivolumab plus Ipilimumab vs. chemotherapy in the treatment of patients having advanced non–small-cell lung cancer.
Usage
data("NivoIpili")Format
A data frame with 1166 observations on the following 3 variables.
timesvector of follow-up times
evntvector of event indicators
trttreatment assignment indicators; 1 - Nivolumab + Ipili, 0 - chemotherapy
Details
Approximate survival data reconstructed from survival curves extracted from Hellmann et al. (2019)
Source
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
References
Hellmann, Matthew D., et al. (2019). "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer." New England Journal of Medicine.
Examples
data(NivoIpili)
head(NivoIpili)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.